High frequency of exon deletions and putative founder effects in French Canadian Lynch Syndrome Families

Human Mutation

Volumn 30, Issue 8, 2009, Pages

  Chong, George ^a   Jarry, Jonathan ^a   Marcus, Victoria ^b   Thiffault, Isabelle ^a   Winocour, Sebastian ^a   Monczak, Yury ^a   Drouin, Régen ^c   Latreille, Jean ^d   Australie, Karlene ^d   Bapat, Bharati ^e   Gordon, Philip H ^a   Giguère, Yves ^f   Gologan, Adrian ^a   Galiatsatos, Polymnia ^a   Jass, Jeremy R ^b   Wong, Nora ^a   Zaor, Sonya ^a   Palma, Laura ^g   Kasprzak, Lidia ^g   Tischkowitz, Marc ^a,b   Foulkes, William D ^a,b,g   more..

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d HÔPITAL CHARLES LEMOYNE   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Colon cancer; French Canadians; HNPCC; Lynch syndrome; Mismatch repair; MLH1; MSH2; MSH6

Indexed keywords

COMPLEMENTARY DNA; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; CANADA; CLINICAL ARTICLE; EXON; FAMILIAL CANCER; FOUNDER EFFECT; FRANCE; GENE DELETION; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BASE SEQUENCE; BLOTTING, SOUTHERN; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA PRIMERS; DNA, COMPLEMENTARY; EXONS; FOUNDER EFFECT; HAPLOTYPES; HUMANS; IMMUNOHISTOCHEMISTRY; QUEBEC;

EID: 67749106239     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21056     Document Type: Article

References (49)

1. Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod SA, Gallinger S. 1996. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet 59:736-739.
2. Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, Hopper JL, Diep A, Bapat B, Salem M, Seminara D, Haile R. 2005. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 293:799-809.
3. Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A, Frebourg T. 2002. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 62:848-853.
4. Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, Saurin JC, Puisieux A, Olschwang S, Frebourg T. 2000. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 60:2760-2763.
5. de la Chapelle A. 2004. Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769-780.
6. De Vos M, Hayward BE, Picton S, Sheridan E, Bonthron DT. 2004. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet 74:954-964.
7. Desai DC, Lockman JC, Chadwick RB, Gao X, Percesepe A, Evans DG, Miyaki M, Yuen ST, Radice P, Maher ER, Wright FA, de la Chapelle A. 2000. Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 37:646-652.
8. Di Fiore F, Charbonnier F, Martin C, Frerot S, Olschwang S, Wang Q, Boisson C, Buisine MP, Nilbert M, Lindblom A, Frebourg T. 2004. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 41:18-20.
9. Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA. 2007. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9:R83.
10. Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Paillerets BB, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, de la CA, Boyd J, Offit K, Rennert G, Chong G, Ellis NA. 2002. The founder mutation MSH2*1906G>C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71:1395-1412.
11. Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH. 2002. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892-897.
12. Kolodner RD, Tytell JD, Schmeits JL, Kane MF, Gupta RD, Weger J, Wahlberg S, Fox EA, Peel D, Ziogas A, Garber JE, Syngal S, Anton-Culver H, Li FP. 1999. Germ-line MSH6 mutations in colorectal cancer families. Cancer Res 59:5068-5074.
13. Laberge AM, Michaud J, Richter A, Lemyre E, Lambert M, Brais B, Mitchell GA. 2005. Population history and its impact on medical genetics in Quebec. Clin Genet 68:287-301.
14. Li L, McVety S, Younan R, Liang P, Du SD, Gordon PH, Hutter P, Hogervorst FB, Chong G, Foulkes WD. 2006. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum Mutat 27:388.
15. Luce MC, Marra G, Chauhan DP, Laghi L, Carethers JM, Cherian SP, Hawn M, Binnie CG, Kam-Morgan LN, Cayouette MC. 1995. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 109:1368-1374.
16. Lynch HT, Coronel SM, Okimoto R, Hampel H, Sweet K, Lynch JF, Barrows A, Wijnen J, van der Klift H, Franken P, Wagner A, Fodde R, de la Chapelle A. 2004. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 291:718-724.
17. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR. 1993. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535-1549.
18. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M. 1999. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23:1248-1255.
19. Mauillon JL, Michel P, Limacher JM, Latouche JB, Dechelotte P, Charbonnier F, Martin C, Moreau V, Metayer J, Paillot B, Frebourg T. 1996. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res 56:5728-5733.
20. McVety S, Li L, Gordon PH, Chong G, Foulkes WD. 2006a. Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family. J Med Genet 43:153-156.
21. McVety S, Li L, Thiffault I, Gordon PH, MacNamara E, Wong N, Australie K, Kasprzak L, Chong G, Foulkes WD. 2006b. The value of multi-modal gene screening in HNPCC in Quebec: three mutations in mismatch repair genes that would have not been correctly identified by genomic DNA sequencing alone. Fam Cancer 5:21-28.
22. Miyaki M, Iijima T, Yamaguchi T, Shirahama S, Ito T, Yasuno M, Mori T. 2004. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family. Mutat Res 548:19-25.
23. Nakagawa H, Hampel H, de la Chapelle A. 2003. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum Mutat 22:258.
24. Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, Jarvinen HJ, Mecklin JP, Kinzler KW, Vogelstein B. 1995. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1:1203-1206.
25. Nystrom-Lahti M, Wu Y, Moisio AL, Hofstra RM, Osinga J, Mecklin JP, Jarvinen HJ, Leisti J, Buys CH, de la Chapelle A, Peltomaki P. 1996. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5:763-769.
26. Oros KK, Ghadirian P, Greenwood CM, Perret C, Shen Z, Paredes Y, Arcand SL, Mes-Masson AM, Narod SA, Foulkes WD, Provencher D, Tonin PN. 2004. Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int J Cancer 112:411-419.
27. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
28. Parc YR, Halling KC, Wang L, Christensen ER, Cunningham JM, French AJ, Burgart LJ, Price-Troska TL, Roche PC, Thibodeau SN. 2000. hMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res 60:2225-2231.
29. Plaschke J, Ruschoff J, Schackert HK. 2003. Genomic rearrangements of hMSH6 contribute to the genetic predisposition in suspected hereditary non-polyposis colorectal cancer syndrome. J Med Genet 40:597-600.
30. Pyatt RE, Nakagawa H, Hampel H, Sedra M, Fuchik MB, Comeras I, de la Chapelle A, Prior TW. 2003. Identification of a deletion in the mismatch repair gene, MSH2, using mouse-human cell hybrids monosomal for chromosome 2. Clin Genet 63:215-218.
31. Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L, Suthers G. 2002. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 34:541-547.
32. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, Du SD, Tucker K, Kirk J. 2001. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68:118-127.
33. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A. 2008. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135:419-428.
34. Simard J, Dumont M, Moisan AM, Gaborieau V, Malouin H, Durocher F, Chiquette J, Plante M, Avard D, Bessette P, Brousseau C, Dorval M, Godard B, Houde L, Joly Y, Lajoie MA, Leblanc G, Lepine J, Lesperance B, Vezina H, Parboosingh J, Pichette R, Provencher L, Rheaume J, Sinnett D, Samson C, Simard JC, Tranchant M, Voyer P, Easton D, Tavtigian SV, Knoppers BM, Laframboise R, Bridge P, Goldgar D. 2007. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet 44:107-121.
35. Simi L, Pratesi N, Vignoli M, Sestini R, Cianchi F, Valanzano R, Nobili S, Mini E, Pazzagli M, Orlando C. 2008. High-Resolution Melting Analysis for Rapid Detection of KRAS, BRAF, and PIK3CA Gene Mutations in Colorectal Cancer. Am J Clin Pathol 130:247-253.
36. Stuckless S, Parfrey PS, Woods MO, Cox J, Fitzgerald GW, Green JS, Green RC. 2007. The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome. Fam Cancer 6:1-12.
37. Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR. 2003. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 22:428-433.
38. Thiffault I, Hamel N, Pal T, McVety S, Marcus VA, Farber D, Cowie S, Deschenes J, Meschino W, Odefrey F, Goldgar D, Graham T, Narod S, Watters AK, MacNamara E, Du SD, Chong G, Foulkes WD. 2004. Germline truncating mutations in both MSH2 and BRCA2 in a single kindred. Br J Cancer 90:483-491.
39. Umar A, Risinger JI, Hawk ET, Barrett JC. 2004. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 4:153-158.
40. van der Klift H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, Kohonen-Corish M, Vasen H, Oliani C, Barana D, Moller P, Delozier-Blanchet C, Hutter P, Foulkes W, Lynch H, Burn J, Moslein G, Fodde R. 2005. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 44:123-138.
41. Viel A, Petronzelli F, Della PL, Lucci-Cordisco E, Fornasarig M, Pucciarelli S, Rovella V, Quaia M, Ponz de L, Boiocchi M, Genuardi M. 2002. Different molecular mechanisms underlie genomic deletions in the MLH1 Gene. Hum Mutat 20:368-374.
42. Wagner A, Hendriks Y, Meijers-Heijboer EJ, de Leeuw WJ, Morreau H, Hofstra R, Tops C, Bik E, Brocker-Vriends AH, van Der Meer C, Lindhout D, Vasen HF, Breuning MH, Cornelisse CJ, van Krimpen C, Niermeijer MF, Zwinderman AH, Wijnen J, Fodde R. 2001. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 38:318-322.
43. Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E. 2003. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 103:636-641.
44. Wang Y, Friedl W, Sengteller M, Jungck M, Filges I, Propping P, Mangold E. 2002. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1. Hum Mutat 19:279-286.
45. Watson P, Lynch HT. 1993. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677-685.
46. Wijnen J, de Leeuw W, Vasen H, van der Klift H, Moller P, Stormorken A, Meijers-Heijboer H, Lindhout D, Menko F, Vossen S, Moslein G, Tops C, Brocker-Vriends A, Wu Y, Hofstra R, Sijmons R, Cornelisse C, Morreau H, Fodde R. 1999. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142-144.
47. Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, Meijers HH, Lindhout D, Moller P, Fodde R. 1998. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 20:326-328.
48. Wimmer K, Etzler J. 2008. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet 124:105-122.
49. Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, Younghusband HB. 2007. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 28:669-673.